The therapeutic potential of apelin in kidney disease.


Journal

Nature reviews. Nephrology
ISSN: 1759-507X
Titre abrégé: Nat Rev Nephrol
Pays: England
ID NLM: 101500081

Informations de publication

Date de publication:
12 2021
Historique:
accepted: 22 06 2021
pubmed: 15 8 2021
medline: 15 12 2021
entrez: 14 8 2021
Statut: ppublish

Résumé

Chronic kidney disease (CKD) is a leading cause of global morbidity and mortality and is independently associated with cardiovascular disease. The mainstay of treatment for CKD is blockade of the renin-angiotensin-aldosterone system (RAAS), which reduces blood pressure and proteinuria and slows kidney function decline. Despite this treatment, many patients progress to kidney failure, which requires dialysis or kidney transplantation, and/or die as a result of cardiovascular disease. The apelin system is an endogenous physiological regulator that is emerging as a potential therapeutic target for many diseases. This system comprises the apelin receptor and its two families of endogenous ligands, apelin and elabela/toddler. Preclinical and clinical studies show that apelin receptor ligands are endothelium-dependent vasodilators and potent inotropes, and the apelin system has a reciprocal relationship with the RAAS. In preclinical studies, apelin regulates glomerular haemodynamics and acts on the tubule to promote aquaresis. In addition, apelin is protective in several kidney injury models. Although the apelin system has not yet been studied in patients with CKD, the available data suggest that apelin is a promising potential therapeutic target for kidney disease.

Identifiants

pubmed: 34389827
doi: 10.1038/s41581-021-00461-z
pii: 10.1038/s41581-021-00461-z
pmc: PMC8361827
doi:

Substances chimiques

Apelin 0
Apelin Receptors 0
Ligands 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

840-853

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/09/002/26360
Pays : United Kingdom
Organisme : British Heart Foundation
ID : TG/18/4/33770
Pays : United Kingdom

Informations de copyright

© 2021. Springer Nature Limited.

Références

Arch Med Sci. 2018 Jun;14(4):725-734
pubmed: 30002688
J Biol Chem. 2015 Jul 24;290(30):18261-8
pubmed: 25995451
J Am Coll Cardiol. 2005 Dec 6;46(11):2116-24
pubmed: 16325051
J Med Chem. 2016 Apr 14;59(7):2962-72
pubmed: 26986036
PLoS One. 2014 Apr 02;9(4):e93473
pubmed: 24695532
JAMA. 2001 Jul 25;286(4):421-6
pubmed: 11466120
Am J Physiol Renal Physiol. 2020 May 1;318(5):F1122-F1135
pubmed: 32174138
Biochem Biophys Res Commun. 2010 Apr 30;395(2):185-9
pubmed: 20353754
Dev Cell. 2007 Mar;12(3):391-402
pubmed: 17336905
Am J Physiol Renal Physiol. 2013 Mar 15;304(6):F788-800
pubmed: 23303408
Int J Mol Sci. 2019 Jan 09;20(2):
pubmed: 30634441
J Am Coll Cardiol. 2019 Oct 29;74(17):2204-2215
pubmed: 31648714
Dev Cell. 2013 Dec 23;27(6):672-80
pubmed: 24316148
FASEB J. 2015 Jan;29(1):314-22
pubmed: 25359495
J Neurochem. 2004 Sep;90(6):1290-301
pubmed: 15341513
Eur J Cancer. 2014 Feb;50(3):663-74
pubmed: 24316062
EMBO Mol Med. 2019 Aug;11(8):e9266
pubmed: 31267692
Cell Metab. 2008 Nov;8(5):437-45
pubmed: 19046574
Biochim Biophys Acta. 2000 Jun 21;1492(1):72-80
pubmed: 11004481
FASEB J. 2007 Jun;21(8):1821-30
pubmed: 17341685
Biopolymers. 2014 Jul;102(4):297-303
pubmed: 24728860
Am J Kidney Dis. 2010 Mar;55(3):441-51
pubmed: 19962808
N Engl J Med. 2020 Oct 8;383(15):1436-1446
pubmed: 32970396
Endocrinology. 2004 Mar;145(3):1342-8
pubmed: 14670994
Dev Cell. 2007 Mar;12(3):403-13
pubmed: 17336906
N Engl J Med. 2019 Feb 7;380(6):539-548
pubmed: 30415601
Bioorg Med Chem. 2014 Jun 1;22(11):2992-7
pubmed: 24755525
Endocrinology. 2005 Apr;146(4):1764-71
pubmed: 15677759
J Biol Chem. 2004 Jun 18;279(25):26274-9
pubmed: 15087458
Regul Pept. 2004 May 15;118(3):119-25
pubmed: 15003827
Clin J Am Soc Nephrol. 2010 Feb;5(2):173-81
pubmed: 20007681
Circulation. 2007 Jul 3;116(1):85-97
pubmed: 17606856
Br J Cancer. 2019 Mar;120(6):633-639
pubmed: 30783205
PLoS One. 2017 Aug 17;12(8):e0183094
pubmed: 28817612
Biochim Biophys Acta. 2013 Jun;1828(6):1471-83
pubmed: 23438363
Front Neurosci. 2017 Feb 28;11:92
pubmed: 28293165
J Physiol. 2014 Feb 1;592(3):505-21
pubmed: 24247978
Biochem Pharmacol. 2008 May 15;75(10):1882-92
pubmed: 18272138
Angiogenesis. 2013 Jul;16(3):723-34
pubmed: 23640575
Circulation. 2017 Mar 21;135(12):1160-1173
pubmed: 28137936
J Clin Invest. 2008 Oct;118(10):3343-54
pubmed: 18769630
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Cancer Res. 2019 May 1;79(9):2298-2313
pubmed: 30718358
Front Physiol. 2015 Apr 10;6:115
pubmed: 25914650
Eur J Heart Fail. 2006 Jun;8(4):355-60
pubmed: 16464638
Blood. 2016 Feb 18;127(7):908-20
pubmed: 26634301
Biochem Pharmacol. 2016 Sep 15;116:63-72
pubmed: 27475715
Am Heart J. 2009 Oct;158(4):629-36
pubmed: 19781424
Structure. 2017 Jun 6;25(6):858-866.e4
pubmed: 28528775
Intensive Care Med. 2015 Aug;41(8):1411-23
pubmed: 26162677
Lancet. 2013 Jul 27;382(9889):339-52
pubmed: 23727170
Circulation. 2003 Sep 23;108(12):1432-9
pubmed: 12963638
Pharmacol Rev. 2019 Oct;71(4):467-502
pubmed: 31492821
Nature. 2017 Aug 31;548(7669):537-542
pubmed: 28783722
Br J Pharmacol. 2001 Mar;132(6):1255-60
pubmed: 11250876
Blood. 2011 Sep 29;118(13):3670-9
pubmed: 21803853
Endocrinology. 2014 Nov;155(11):4483-93
pubmed: 25157454
Gene Expr Patterns. 2007 Jan;7(3):258-65
pubmed: 17085078
Gene. 1993 Dec 22;136(1-2):355-60
pubmed: 8294032
J Clin Endocrinol Metab. 2013 May;98(5):2084-9
pubmed: 23515451
Circ Res. 2002 Sep 6;91(5):434-40
pubmed: 12215493
FEBS Open Bio. 2013 Aug 09;3:328-33
pubmed: 24251091
Biochem Biophys Res Commun. 2002 Jan 11;290(1):539-45
pubmed: 11779205
Circ Heart Fail. 2013 May;6(3):482-91
pubmed: 23519586
J Biol Chem. 2002 Apr 26;277(17):14838-43
pubmed: 11815627
Peptides. 2019 Nov;121:170139
pubmed: 31472173
Endocrinology. 2004 Sep;145(9):4392-400
pubmed: 15166125
Hypertens Res. 2011 Jun;34(6):701-6
pubmed: 21412239
Nephron Extra. 2012 Jan;2(1):39-47
pubmed: 22619666
Am J Kidney Dis. 2018 Nov;72(5):682-690
pubmed: 30007506
Ther Apher Dial. 2016 Oct;20(5):517-522
pubmed: 26991810
J Neurochem. 2000 Jan;74(1):34-41
pubmed: 10617103
Expert Opin Ther Targets. 2019 Mar;23(3):215-225
pubmed: 30570369
Transplant Proc. 2017 Jul - Aug;49(6):1499-1509
pubmed: 28736029
Chembiochem. 2016 Aug 17;17(16):1495-8
pubmed: 27377680
N Engl J Med. 2019 Jun 13;380(24):2295-2306
pubmed: 30990260
J Clin Endocrinol Metab. 2016 May;101(5):1917-23
pubmed: 26967692
Basic Clin Pharmacol Toxicol. 2020 Jun;126 Suppl 6:96-103
pubmed: 30901161
Cell Death Dis. 2017 Aug 24;8(8):e3006
pubmed: 28837139
J Med Chem. 2017 Jul 27;60(14):6408-6427
pubmed: 28685579
Brain. 2017 Nov 1;140(11):2939-2954
pubmed: 29053791
Dev Cell. 2017 Sep 25;42(6):655-666.e3
pubmed: 28890073
Cardiovasc Res. 2005 Jan 1;65(1):73-82
pubmed: 15621035
Int J Mol Med. 2005 Nov;16(5):787-92
pubmed: 16211245
Lancet. 2017 Mar 25;389(10075):1238-1252
pubmed: 27887750
Hypertension. 2009 Sep;54(3):598-604
pubmed: 19597036
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
J Thorac Oncol. 2010 Aug;5(8):1120-9
pubmed: 20581707
Curr Gene Ther. 2017;16(5):349-360
pubmed: 27903222
J Biol Chem. 2006 Jul 7;281(27):18317-26
pubmed: 16679320
Peptides. 2013 Nov;49:1-8
pubmed: 23973863
In Vivo. 2017 01-02;31(1):1-22
pubmed: 28064215
Regul Pept. 2001 Jun 15;99(2-3):87-92
pubmed: 11384769
Anal Biochem. 2013 Nov 1;442(1):1-9
pubmed: 23872001
Cardiovasc Res. 2017 Jun 01;113(7):760-769
pubmed: 28371822
Hypertension. 2016 Aug;68(2):365-77
pubmed: 27217402
Am J Pathol. 2007 Nov;171(5):1705-12
pubmed: 17884970
Arch Intern Med. 2004 Mar 22;164(6):659-63
pubmed: 15037495
Circulation. 2004 Sep 14;110(11 Suppl 1):II187-93
pubmed: 15364861
J Surg Res. 2020 Mar;247:429-437
pubmed: 31662185
Science. 2014 Feb 14;343(6172):1248636
pubmed: 24407481
Circ Res. 2000 Sep 1;87(5):E1-9
pubmed: 10969042
Biochemistry. 2009 Jan 27;48(3):537-48
pubmed: 19123778
Regul Pept. 2005 Mar 30;126(3):233-40
pubmed: 15664671
Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1717-22
pubmed: 18599802
PLoS One. 2013 Jul 16;8(7):e69703
pubmed: 23874984
Endocrinology. 2005 Jan;146(1):231-6
pubmed: 15486224
ChemMedChem. 2012 Feb 6;7(2):318-25
pubmed: 22170700
Biochim Biophys Acta. 2015 Jul;1852(7):1278-87
pubmed: 25748499
Sci Rep. 2015 Feb 02;5:8170
pubmed: 25639753
Eur J Clin Invest. 2013 Jan;43(1):34-40
pubmed: 23106642
Virology. 2003 Mar 1;307(1):22-36
pubmed: 12667811
Cell Physiol Biochem. 2019;53(4):687-700
pubmed: 31577078
J Biol Chem. 2000 Jul 14;275(28):21061-7
pubmed: 10777510
J Am Soc Nephrol. 2006 Apr;17(4):943-55
pubmed: 16540557
Kidney Int. 2019 Jan;95(1):160-172
pubmed: 30473140
J Clin Invest. 2020 Jan 2;130(1):94-107
pubmed: 31738185
Nature. 2020 Dec;588(7837):327-330
pubmed: 32942285
Int J Ophthalmol. 2014 Dec 18;7(6):968-73
pubmed: 25540748
J Am Coll Cardiol. 2008 Sep 9;52(11):908-13
pubmed: 18772060
Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10464-9
pubmed: 15231996
Circ Res. 2008 Aug 15;103(4):432-40
pubmed: 18617693
Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):917-25
pubmed: 20943064
Biochem Biophys Res Commun. 2003 Aug 29;308(3):480-5
pubmed: 12914775
Ann N Y Acad Sci. 2019 Nov;1455(1):12-33
pubmed: 31236974
Biochim Biophys Acta. 2001 Apr 23;1538(2-3):162-71
pubmed: 11336787
Eur Heart J. 2006 Jan;27(2):222-6
pubmed: 16278229
Lancet. 2020 Feb 29;395(10225):709-733
pubmed: 32061315
Diabetes Care. 2012 Mar;35(3):556-64
pubmed: 22301125
Basic Res Cardiol. 2016 Jan;111(1):2
pubmed: 26611206
Oral Oncol. 2012 Jun;48(6):500-6
pubmed: 22285858
N Engl J Med. 1996 Apr 11;334(15):939-45
pubmed: 8596594
J Clin Invest. 2013 Dec;123(12):5203-11
pubmed: 24177423
Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2540-6
pubmed: 18424641
J Neurochem. 2003 Mar;84(5):1162-72
pubmed: 12603839
Exp Ther Med. 2012 May;3(5):908-914
pubmed: 22969992
Int Heart J. 2019 Jan 25;60(1):145-150
pubmed: 30518720
JCI Insight. 2020 Apr 23;5(8):
pubmed: 32208384
Physiol Rep. 2018 Dec;6(23):e13939
pubmed: 30548130
Hypertension. 2017 Dec;70(6):1165-1175
pubmed: 28974565
Dev Biol. 2006 Aug 1;296(1):177-89
pubmed: 16750822
Clin Exp Pharmacol Physiol. 2020 Mar;47(3):393-402
pubmed: 31630435
J Hypertens. 2011 Apr;29(4):724-31
pubmed: 21358420
ChemMedChem. 2011 Jun 6;6(6):1017-23
pubmed: 21560248
FASEB J. 2020 Jun;34(6):7989-8000
pubmed: 32301550
Nature. 2012 Aug 16;488(7411):394-8
pubmed: 22810587
Cell Rep. 2017 Aug 29;20(9):2116-2130
pubmed: 28854362
EMBO J. 2008 Feb 6;27(3):522-34
pubmed: 18200044
PLoS One. 2013;8(4):e60457
pubmed: 23577111
Am J Physiol Renal Physiol. 2017 Jul 1;313(1):F1-F8
pubmed: 28274926
FASEB J. 2018 Aug;32(8):4315-4327
pubmed: 29522374
JCI Insight. 2020 Sep 3;5(17):
pubmed: 32879139
Kidney Int. 2008 Aug;74(4):486-94
pubmed: 18509323
JCI Insight. 2020 Jul 23;5(14):
pubmed: 32516140
J Neurochem. 2001 May;77(4):1085-96
pubmed: 11359874
J Cardiovasc Med (Hagerstown). 2014 Aug;15(8):642-6
pubmed: 24933193
Biochem Biophys Res Commun. 1998 Oct 20;251(2):471-6
pubmed: 9792798
J Am Heart Assoc. 2013 Jul 01;2(4):e000249
pubmed: 23817469
Circulation. 2010 Apr 27;121(16):1818-27
pubmed: 20385929
J Cardiovasc Pharmacol. 2010 Jan;55(1):83-8
pubmed: 19904215
N Engl J Med. 2004 Sep 23;351(13):1285-95
pubmed: 15385655
Biochim Biophys Acta. 1999 Oct 13;1452(1):25-35
pubmed: 10525157
Peptides. 2013 Aug;46:76-82
pubmed: 23727032
Biochem Biophys Res Commun. 2007 Jun 15;357(4):889-95
pubmed: 17466269
Circ Res. 2007 Aug 17;101(4):e32-42
pubmed: 17673668
Am J Hypertens. 2010 Mar;23(3):282-9
pubmed: 20019670
Oncogene. 2007 Dec 6;26(55):7692-9
pubmed: 17563744
Ann Intern Med. 2003 Aug 19;139(4):244-52
pubmed: 12965979
Eur J Med Chem. 2019 Mar 15;166:119-124
pubmed: 30690406
Am J Kidney Dis. 1996 Mar;27(3):347-54
pubmed: 8604703
Mol Genet Metab. 2016 Sep;119(1-2):20-7
pubmed: 27650065
Amino Acids. 2014 Dec;46(12):2693-704
pubmed: 25164121
Am J Kidney Dis. 2017 Jan;69(1):18-28
pubmed: 27555107
Kidney Int. 2011 Dec;80(12):1258-70
pubmed: 21993585
Am J Physiol Endocrinol Metab. 2010 Jun;298(6):E1161-9
pubmed: 20233941
Hypertension. 2015 Apr;65(4):834-40
pubmed: 25712721
J Am Soc Nephrol. 2008 May;19(5):1015-24
pubmed: 18272843
Mol Vis. 2013 Nov 07;19:2227-36
pubmed: 24227918
J Mol Cell Cardiol. 2006 Nov;41(5):798-806
pubmed: 16919293
J Neurochem. 2001 Apr;77(2):476-85
pubmed: 11299310
Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1904-13
pubmed: 19767528
Mol Cell Endocrinol. 2016 Dec 5;437:108-119
pubmed: 27492965
Ann Intern Med. 2013 Jun 4;158(11):825-30
pubmed: 23732715
J Cell Mol Med. 2015 Sep;19(9):2273-85
pubmed: 26103809
Sci Rep. 2019 Dec 27;9(1):19934
pubmed: 31882594
Nat Rev Mol Cell Biol. 2018 Oct;19(10):638-653
pubmed: 30104700
J Am Soc Nephrol. 2017 Sep;28(9):2812-2823
pubmed: 28642330
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):13006-13015
pubmed: 31189595
Regul Pept. 2007 Dec 4;144(1-3):50-5
pubmed: 17628718
J Am Soc Nephrol. 2017 Sep;28(9):2694-2707
pubmed: 28583915
Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4237-42
pubmed: 20220056
J Pathol. 2004 Jul;203(3):740-3
pubmed: 15221932
Dev Biol. 2007 May 15;305(2):599-614
pubmed: 17412318

Auteurs

Fiona A Chapman (FA)

BHF/University Centre for Cardiovascular Science, The Queen's Medical Research Institute, Edinburgh, UK.
Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.

Duuamene Nyimanu (D)

Division of Experimental Medicine and Immunotherapeutics, Addenbrooke's Centre for Clinical Investigation, University of Cambridge, Cambridge, UK.

Janet J Maguire (JJ)

Division of Experimental Medicine and Immunotherapeutics, Addenbrooke's Centre for Clinical Investigation, University of Cambridge, Cambridge, UK.

Anthony P Davenport (AP)

Division of Experimental Medicine and Immunotherapeutics, Addenbrooke's Centre for Clinical Investigation, University of Cambridge, Cambridge, UK.

David E Newby (DE)

BHF/University Centre for Cardiovascular Science, The Queen's Medical Research Institute, Edinburgh, UK.

Neeraj Dhaun (N)

BHF/University Centre for Cardiovascular Science, The Queen's Medical Research Institute, Edinburgh, UK. bean.dhaun@ed.ac.uk.
Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK. bean.dhaun@ed.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH